Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZKY001 for Corneal Epithelial Defects After TPRK
NCT06209203Phase 2Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Aug 2022
- Primary completion
- Nov 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of germinal peptide in Corneal epithelial defect, sponsored by Zhaoke Ophthalmology. Started Aug 2022; status: completed.
02
Drugs
germinal peptide
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT06209203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06209203.